Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomic Selection Platform Market Value Expansion And Long-Term Growth Outlook

Within the realm of genomic selection platforms, a significant expansion has been observed recently. Projections indicate a robust increase from $2.27 billion in 2025 to an estimated $2.66 billion by 2026, reflecting a compound annual growth rate of 17.1%. This upward trajectory during the preceding period was fueled by several key factors, including the widespread implementation of molecular breeding initiatives, the advancing accessibility of genotyping techniques, the integration of statistical genomics models, a growing need for accelerated breeding processes, and escalating financial commitments to genetic research.

The market for genomic selection platforms is poised for substantial expansion over the coming years, projected to reach $4.96 billion by 2030 with a compound annual growth rate of 16.8%. This projected growth is fueled by several key factors, including the increasing integration of genomic selection within agricultural practices, a heightened reliance on predictive analytics for breeding initiatives, the burgeoning field of sustainable agriculture and livestock development, the growing synergy between genomics and precision agriculture, and the ongoing evolution of cloud-native genomic solutions. During this forecast period, prominent trends will involve a greater embrace of AI-powered genomic prediction models, expanded utilization of high-throughput genotyping technologies, deeper integration of cloud-based breeding analytics, the proliferation of predictive breeding decision support systems, and a more concentrated emphasis on achieving superior accuracy in trait-based selection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Genomic Selection Platform Market Expansion Drivers: What Is Shaping Future Growth?

A significant catalyst for the expansion of the genomic selection platform market is the increasing emphasis on personalized medicine. This approach customizes healthcare strategies based on an individual’s distinct genetic profile, habits, and surroundings. The growing prevalence of personalized medicine stems largely from innovations in genomics, which allow for the accurate identification of genetic variations and the development of individualized therapies. Genomic selection platforms play a crucial role in facilitating personalized medicine by offering detailed genetic insights, thereby enabling the precise tailoring of treatments to each patient. By predicting responses to various interventions, these platforms minimize the hit-or-miss nature of treatment selection, leading to more effective therapies and better patient results. For example, the Personalized Medicine Coalition (PMC) noted that in 2023, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines, a notable increase from the 12 approved in 2022, highlighting the growing momentum of this field and, consequently, the demand for genomic selection platforms.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

The anticipated rise in crop yields is poised to stimulate the expansion of the genomic selection platform market. Crop yield, representing the agricultural output per unit of land, is experiencing an upswing thanks to progress in agricultural biotechnology that strengthens plant genetics and their capacity to withstand environmental challenges. Genomic selection platforms contribute to augmenting crop yields by facilitating the accurate identification and selection of superior plant varieties, making them invaluable tools for contemporary agriculture and breeding initiatives. These platforms streamline the breeding process, reducing both the time and expenses associated with traditional methods through precise genetic forecasting, ultimately boosting agricultural productivity and bolstering global food security. Illustrating this trend, the Central Statistics Office of Ireland reported in May 2025 that potato production saw a substantial annual increase of 46,100 tonnes, reaching 368,300 tonnes in 2024. Furthermore, potato yield per hectare grew by 1.0% to 39.6 tonnes, with the cultivation area expanding by 1,100 hectares (13.2%) compared to the previous year, covering 9,300 hectares in 2024. This demonstrable growth in crop yields underscores the market-driving influence of increased agricultural output on the genomic selection platform sector.

Genomic Selection Platform Market Segmentation And Category Breakdown

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Genomic Selection Platform Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies prominent within the genomic selection platform sector are dedicating their efforts toward creating novel solutions, including sophisticated targeted sequencing platforms, with the aim of enhancing trait prediction accuracy and expediting the progression of breeding initiatives. These targeted sequencing platforms represent advanced genomic technologies and systems engineered for the precise sequencing of predetermined genomic areas, rather than encompassing the entirety of the genome. Illustrating this trend, in October 2024, Element Biosciences Inc., a biotechnology firm headquartered in the United States, introduced Trinity, a revolutionary targeted sequencing platform. This innovative system simplifies the process of exome capture by incorporating steps that were previously intricate directly into their AVITI System. The Trinity platform eradicates the requirement for specialized instrumentation, curtails manual labor by as much as five hours, and provides a hybridization option that can yield results within a single hour, thus proving exceptionally beneficial for time-critical research. Furthermore, Trinity accommodates custom panels catering to a broad spectrum of applications, including oncology, respiratory ailments, and the detection of minimal residual disease (MRD), thereby facilitating quicker, more economical, and readily accessible sequencing, signifying a significant leap forward in exome capture technology.

Genomic Selection Platform Market Competitive Analysis Of Major Industry Participants

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Access The Complete Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Genomic Selection Platform Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model